Literature DB >> 1633068

The influence of renal function on the renal clearance of morphine and its glucuronide metabolites in intensive-care patients.

R W Milne1, R L Nation, A A Somogyi, F Bochner, W M Griggs.   

Abstract

1. The relationships between renal creatinine clearance and the renal clearances of morphine, morphine-3-glucuronide (M3G) and morphine-6-glucuronide (M6G) were studied in fifteen intensive-care patients who were receiving morphine sulphate by constant intravenous infusion and who had diverse renal function. 2. An arterial blood sample was collected before and after a 4-5 h urine collection. Plasma and urine concentrations of morphine, M3G and M6G were measured by h.p.l.c. Plasma binding of all three compounds in drug-free plasma from healthy volunteers was determined by ultrafiltration. Measured renal creatinine clearance (CLCr,meas) was calculated from plasma and urinary creatinine concentrations (from h.p.l.c.). Also, creatinine clearance was predicted (CLCr,pred) from routine laboratory determination of plasma creatinine (Jaffe method). 3. There were significant linear relationships (P less than 0.001) between CLCr,meas and the renal clearances of morphine, M3G and M6G. The unbound renal clearance of morphine exceeded CLCr,meas (P less than 0.002) while the unbound renal clearances of M3G and M6G did not differ from CLCr,meas (P greater than 0.5). 4. In ten of the patients who received a constant infusion of morphine for at least 6 h, the dose-normalised plasma concentrations of M3G and M6G increased with decreasing CLCr,pred. Significant (P less than 0.001) relationships were observed between the reciprocal of CLCr,pred and the dose-normalised plasma concentrations of M3G and M6G. 5. The results indicate the importance of renal function in determining the renal clearances and plasma concentrations of M3G and M6G during intravenous infusion with morphine in intensive-care patients.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1633068      PMCID: PMC1381375          DOI: 10.1111/j.1365-2125.1992.tb04107.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  33 in total

1.  Narcotic analgesics in anuric patients.

Authors:  H F Don; R A Dieppa; P Taylor
Journal:  Anesthesiology       Date:  1975-06       Impact factor: 7.892

2.  Assessment of creatinine clearance in intensive care patients.

Authors:  C Martin; M Alaya; J Bras; P Saux; F Gouin
Journal:  Crit Care Med       Date:  1990-11       Impact factor: 7.598

3.  Prediction of creatinine clearance from serum creatinine.

Authors:  D W Cockcroft; M H Gault
Journal:  Nephron       Date:  1976       Impact factor: 2.847

4.  High-performance liquid chromatographic determination of morphine and its 3- and 6-glucuronide metabolites: improvements to the method and application to stability studies.

Authors:  R W Milne; R L Nation; G D Reynolds; A A Somogyi; J T Van Crugten
Journal:  J Chromatogr       Date:  1991-04-19

5.  The tubular transport and metabolism of morphine-N-methyl-C14 by the chicken kidney.

Authors:  D G May; J M Fujimoto; C E Inturrisi
Journal:  J Pharmacol Exp Ther       Date:  1967-09       Impact factor: 4.030

6.  Antinociceptive and ventilatory effects of the morphine metabolites: morphine-6-glucuronide and morphine-3-glucuronide.

Authors:  Q L Gong; T Hedner; J Hedner; R Björkman; G Nordberg
Journal:  Eur J Pharmacol       Date:  1991-01-25       Impact factor: 4.432

7.  Analgesic effect of morphine glucuronides.

Authors:  K Shimomura; O Kamata; S Ueki; S Ida; K Oguri; H Yoshimura; H Tsukamoto
Journal:  Tohoku J Exp Med       Date:  1971-09       Impact factor: 1.848

8.  Endogenous creatinine clearance and serum creatinine in the clinical assessment of kidney function.

Authors:  A Rapoport; H Husdan
Journal:  Can Med Assoc J       Date:  1968-07-27       Impact factor: 8.262

9.  Validity of creatinine clearance estimates in the assessment of renal function.

Authors:  D R Luke; C E Halstenson; J A Opsahl; G R Matzke
Journal:  Clin Pharmacol Ther       Date:  1990-11       Impact factor: 6.875

10.  Influence of renal function on the elimination of morphine and morphine glucuronides.

Authors:  J Wolff; D Bigler; C B Christensen; S N Rasmussen; H B Andersen; K H Tønnesen
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

View more
  24 in total

Review 1.  Implications of opioid analgesia for medically complicated patients.

Authors:  Howard Smith; Patricia Bruckenthal
Journal:  Drugs Aging       Date:  2010-05       Impact factor: 3.923

Review 2.  Drugs and brain death.

Authors:  M Kennedy; N Kiloh
Journal:  Drug Saf       Date:  1996-03       Impact factor: 5.606

Review 3.  Opioid metabolism.

Authors:  Howard S Smith
Journal:  Mayo Clin Proc       Date:  2009-07       Impact factor: 7.616

Review 4.  Pharmacokinetic and pharmacodynamic principles of illicit drug use and treatment of illicit drug users.

Authors:  D I Quinn; A Wodak; R O Day
Journal:  Clin Pharmacokinet       Date:  1997-11       Impact factor: 6.447

Review 5.  Principles of drug administration in renal insufficiency.

Authors:  Y W Lam; S Banerji; C Hatfield; R L Talbert
Journal:  Clin Pharmacokinet       Date:  1997-01       Impact factor: 6.447

Review 6.  Pharmacokinetic and pharmacodynamic considerations when treating patients with sepsis and septic shock.

Authors:  Peter De Paepe; Frans M Belpaire; Walter A Buylaert
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

Review 7.  Sedation for critically ill or injured adults in the intensive care unit: a shifting paradigm.

Authors:  Derek J Roberts; Babar Haroon; Richard I Hall
Journal:  Drugs       Date:  2012-10-01       Impact factor: 9.546

8.  A Comprehensive Whole-Body Physiologically Based Pharmacokinetic Model of Dabigatran Etexilate, Dabigatran and Dabigatran Glucuronide in Healthy Adults and Renally Impaired Patients.

Authors:  Daniel Moj; Hugo Maas; André Schaeftlein; Nina Hanke; José David Gómez-Mantilla; Thorsten Lehr
Journal:  Clin Pharmacokinet       Date:  2019-12       Impact factor: 6.447

Review 9.  Pharmacokinetics of opioids in renal dysfunction.

Authors:  G Davies; C Kingswood; M Street
Journal:  Clin Pharmacokinet       Date:  1996-12       Impact factor: 6.447

10.  Pharmacodynamic Analysis of Morphine Time-to-Remedication Events in Infants and Young Children After Congenital Heart Surgery.

Authors:  Mohammed H Elkomy; David R Drover; Jeffery L Galinkin; Gregory B Hammer; Kristi L Glotzbach
Journal:  Clin Pharmacokinet       Date:  2016-10       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.